RESUMO
BACKGROUND: Recurrent pregnancy loss (RPL), defined as two or more miscarriages, affects 3-5% of couples trying to establish a family. Despite extensive evaluation, no factor is identified in â¼40% of cases. In this study, we investigated the possibility that submicroscopic chromosomal changes, not detectable by conventional cytogenetic analysis, exist in miscarriages with normal karyotypes (46,XY or 46,XX) from couples with idiopathic RPL. METHODS: Array comparative genomic hybridization (array-CGH) was used to assess for DNA copy number variants (CNVs) in 26 miscarriages with normal karyotypes. Parental array-CGH analysis was performed to determine if miscarriage CNVs were de novo or inherited. RESULTS: There were 11 unique (previously not described) CNVs, all inherited, identified in 13 miscarriages from 8 couples. The maternal origin of two CNVs was of interest as they involved the imprinted genes TIMP2 and CTNNA3, which are only normally expressed from the maternal copy in the placenta. Two additional cohorts, consisting of 282 women with recurrent miscarriage (RM) and 61 fertile women, were screened for these two CNVs using a Quantitative Multiplex Fluorescent PCR of Short Fragments assay. One woman with RM, but none of the fertile women, carried the CTNNA3-associated CNV. CONCLUSIONS: This preliminary study shows that array-CGH is useful for detecting CNVs in cases of RPL. Further investigations of CNVs, particularly those involving genes that are imprinted in placenta, in women with RPL could be worthwhile.
Assuntos
Aborto Habitual/genética , Variações do Número de Cópias de DNA/genética , Hibridização Genômica Comparativa , Feminino , Humanos , Gravidez , Inibidor Tecidual de Metaloproteinase-2/genética , alfa Catenina/genéticaRESUMO
The Fragile X syndrome is a common form of X-linked mental retardation, affecting approximately 1 in 4,000 males. Since the discovery of the FMR1 gene responsible for the syndrome, molecular, rather than cytogenetic, diagnosis of Fragile X syndrome has become the gold standard. Numerous molecular diagnostic centers worldwide use PCR and Southern blotting to characterize the size of the CGG repeats within the gene, expansion of which has been shown to be associated with the vast majority of cases of Fragile X syndrome. Instability of this repeat through successive generations has been demonstrated in many patients and has been associated with numerous factors, including repeat length and molecular structure of the repeat. Nine males with normal-size alleles that exhibit repeat length instability by the presence of a second normal length distinct band by repeated PCR analysis from peripheral lymphocytes are reported. Many hypotheses addressing the reason for this apparent instability were tested without elucidating the underlying molecular causes, including cytogenetic analysis, sequence analysis of the repeat locus, and analysis of flanking dinucleotide repeat loci. All patients exhibited a normal complement of sex chromosomes by cytogenetic and molecular analysis. These results from the widely used PCR analysis illustrate an interesting molecular phenomenon and raise many questions relating to the factors and mechanisms involved in trinucleotide instability as well as having implications for the diagnostic testing of the Fragile X syndrome.
Assuntos
Deficiências do Desenvolvimento/diagnóstico , Síndrome do Cromossomo X Frágil/genética , Proteínas do Tecido Nervoso/genética , Proteínas de Ligação a RNA , Alelos , Southern Blotting , Criança , Análise Citogenética , Deficiências do Desenvolvimento/genética , Proteína do X Frágil da Deficiência Intelectual , Síndrome do Cromossomo X Frágil/diagnóstico , Humanos , Masculino , Reação em Cadeia da Polimerase , Valor Preditivo dos Testes , Repetições de TrinucleotídeosAssuntos
Hemocromatose/diagnóstico , Hemocromatose/genética , Íntrons/genética , Mutação/genética , Polimorfismo Genético/genética , Adulto , Idoso , Alelos , Sequência de Bases , Análise Mutacional de DNA , Desoxirribonucleases de Sítio Específico do Tipo II/metabolismo , Feminino , Homozigoto , Humanos , Masculino , Dados de Sequência Molecular , Núcleo Familiar , Reação em Cadeia da PolimeraseRESUMO
The molecular genetic diagnosis of spinal muscular atrophy (SMA) has recently been complicated by the identification of two candidate genes, which are often deleted in affected individuals but are also occasionally deleted in apparently unaffected carriers. We present a compilation of genotypes, from our laboratory and recent reports, for the survival motor neuron (SMN) and neuronal apoptosis inhibitor protein (NAIP) genes. Bayesian analyses were used to generate probabilities for SMA when deletions are present or absent in SMN. We found that when the SMN(T) exon 7 is deleted, the probability of SMA can reach greater than 98% in some populations, and when SMN(T) is present, the probability of SMA is approximately 17 times less than the prior population risk. Deletion of NAIP exon 5, as well as SMN(T) exon 7, is associated with a 5-fold increased risk of type I SMA. Case studies are used to illustrate differing disease risks for pre- and postnatal testing, depending on the presence of information about clinical status or molecular results. These analyses demonstrate that deletion screening of candidate genes can be a powerful tool in the diagnosis of SMA.
Assuntos
Análise Mutacional de DNA , Atrofia Muscular Espinal/diagnóstico , Atrofia Muscular Espinal/genética , Proteínas do Tecido Nervoso/genética , Deleção de Sequência/genética , Proteína de Ligação ao Elemento de Resposta ao AMP Cíclico , Éxons/genética , Humanos , Mutação , Proteína Inibidora de Apoptose Neuronal , Linhagem , Reação em Cadeia da Polimerase , Proteínas de Ligação a RNA , Proteínas do Complexo SMNRESUMO
Myotonic dystrophy (DM) is the most common form of inherited neuromuscular disease in adults and is characterized by progressive muscle wasting and myotonia. The mutation responsible for DM has been identified as the amplification of a polymorphic (CTG)n repeat in the 3' untranslated region of a gene encoding a serine/threonine kinase (DMK). We have produced a polyclonal rabbit antibody preparation against a fusion protein encoding the C-terminal amino acids 471-629 of the human DMK gene. This antibody specifically detects products of both full length and truncated human DMK genes expressed in bacteria and in insect cells. On immunoblots, we observed protein species of approximately 74 and 82 kDa in cardiac muscle, skeletal muscle, ependyma and choroid plexus. By immunofluorescence, DMK was found to localize post-synaptically at the neuromuscular junction of skeletal muscle, at intercalated discs of cardiac tissue and at the apical membrane of the ependyma and choroid plexus. We have also detected two to three species (approximately 45-50 kDa) in other regions of the brain. Synaptic localization of DMK in the cerebellum, hippocampus, midbrain and medulla was noted. These results suggest that DMK plays a specialized role in intercellular communication.
Assuntos
Encéfalo/enzimologia , Músculo Esquelético/enzimologia , Miocárdio/enzimologia , Proteínas Serina-Treonina Quinases/metabolismo , Idoso , Animais , Sequência de Bases , Encéfalo/embriologia , Encéfalo/ultraestrutura , Glutationa Transferase/genética , Glutationa Transferase/imunologia , Humanos , Immunoblotting , Imunoglobulina G/imunologia , Masculino , Dados de Sequência Molecular , Músculo Esquelético/ultraestrutura , Miocárdio/ultraestrutura , Miotonina Proteína Quinase , Proteínas Serina-Treonina Quinases/genética , Proteínas Serina-Treonina Quinases/imunologia , Ratos , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/imunologiaRESUMO
Mutations of the Cu/Zn superoxide dismutase (SOD-1) gene were recently implicated in the pathogenesis of familial amyotrophic lateral sclerosis (ALS). We measured SOD-1 mRNA levels in motorneurons of the more common sporadic form of the disease and found a 42% increase in ALS motorneurons (P = 0.058) as compared with controls. These results suggest that oxidative stress may also play a role in the pathogenesis of sporadic ALS.
Assuntos
Esclerose Lateral Amiotrófica/metabolismo , Neurônios Motores/metabolismo , RNA Mensageiro/metabolismo , Superóxido Dismutase/genética , Adulto , Idoso , Esclerose Lateral Amiotrófica/patologia , Humanos , Hibridização In Situ , Pessoa de Meia-Idade , Estresse Oxidativo , Valores de ReferênciaRESUMO
The presence of large neurofilamentous accumulations in the perikaryon and proximal axon of motor neurons in amyotrophic lateral sclerosis (ALS) suggests that the expression of this abundant cytoskeletal protein may be altered. We performed quantitative in situ hybridization for the low molecular weight neurofilament subunit (NF-L) messenger RNA in six cases of sporadic ALS and six controls. We found a 41% decrease (p < 0.02) in the NF-L mRNA levels in anterior horn cells in ALS, with a 60% decrease (p < or = 0.01) in alpha motor neurons. This alteration may represent a non-specific response to axonal or neuronal injury or, alternatively, reflect the regenerative activity of residual normal motor neurons. NF-L mRNA levels were consistently low (in the third and fourth quartiles) in spheroid-bearing motor neurons, indicating that the neurofilamentous accumulations observed in ALS are not likely the result of overexpression of the NF-L gene. Total neuronal polyadenylated mRNA levels were also 50% lower (p = 0.02) in anterior horn cells and 48% lower (p < or = 0.05) in alpha motor neurons in ALS, possibly reflecting a decrease in selected mRNA species in diseased motor neurons.
Assuntos
Esclerose Lateral Amiotrófica/metabolismo , Neurônios Motores/metabolismo , Proteínas de Neurofilamentos/genética , Proteínas de Neurofilamentos/metabolismo , Poli A/metabolismo , RNA Mensageiro/metabolismo , Adulto , Idoso , Esclerose Lateral Amiotrófica/genética , Expressão Gênica , Humanos , Hibridização In Situ , Pessoa de Meia-IdadeRESUMO
We have further characterized an unusual 22p+ marker chromosome with a double nucleolus organizer region (dNOR) previously identified in a family with late-onset dementia of the Alzheimer type. G-banding and morphology of the marker's q arm were typically normal. However, the p+ arm had a terminal cytological satellite and a GT-positive region at the midpoint. Standard C-banding documented 2 C-positive regions: one was associated with the primary centromere; the other, which was at the midpoint of the p arm, was not associated with a constriction. With replication-banding, there was a darkly staining region in the middle of the p+ arm that resembled the pericentromeric region of a chromosome 21 or 22. Fluorescence in situ hybridization with pXlr 101, a probe recognizing the full repeating unit of rDNA, indicated that the marker had an unusually larger rDNA region; with pU 1.2, a probe recognizing the human rDNA promoter, the signal was a doublet. The marker had 2 signals with a beta-satellite probe, and a second signal in addition to that present at the primary centromere under low stringency with alpha-satellite probes and a classic satellite probe. Immunostaining of chromosome spreads after R-banding and ultraviolet (UV) denaturation showed that the major portion of the marker's p arm was highly methylated.
Assuntos
Doença de Alzheimer/genética , Cromossomos Humanos Par 22 , Marcadores Genéticos , Região Organizadora do Nucléolo/patologia , Idoso , Centrômero/química , Bandeamento Cromossômico/métodos , DNA Satélite/análise , Feminino , Humanos , Hibridização in Situ Fluorescente , RNA Ribossômico/análise , Sequências Repetitivas de Ácido Nucleico , Coloração e RotulagemRESUMO
Disturbances in calcium homeostasis have been observed to be associated with Alzheimer's and other neurodegenerative diseases. Increased total calcium levels and decreased levels of calcium binding proteins have been found in Alzheimer brain tissue. However, the mechanism behind these disturbances remain unknown. In situ hybridization with tritiated antisense RNA probes for the calcium binding proteins, calbindin-28k and calmodulin, was used to examine the expression of genes coding for these proteins in Alzheimer and Huntington brain tissues matched for age, agonal process and autopsy interval. mRNA levels for calbindin-28k were reduced by 35% in CA1 and CA2 regions of Alzheimer hippocampus, as compared to Huntington control. In contrast, calmodulin expression was unchanged in CA1 but reduced by 30% in CA2. mRNA expression of calbindin-28k and calmodulin in Alzheimer temporal cortex did not differ from control. There were no significant differences in calcium binding protein message levels in cerebellar Purkinje cells between Alzheimer and Huntington control. There was no correlation between calcium binding protein message levels and brain weight, autopsy interval, patient age or the extent of neurofibrillary degeneration. Instead, decreased calbindin-28k expression in Alzheimer-affected hippocampus was due to an increase in the percentage of neurons expressing lower message levels for these proteins.
Assuntos
Doença de Alzheimer/metabolismo , Hipocampo/química , Doença de Huntington/metabolismo , Proteínas do Tecido Nervoso/deficiência , Proteína G de Ligação ao Cálcio S100/análise , Idoso , Animais , Calbindinas , Cálcio/metabolismo , Cerebelo/química , Homeostase , Humanos , Hibridização In Situ , Pessoa de Meia-Idade , Proteínas do Tecido Nervoso/análise , Neurônios/química , RNA Mensageiro/análise , Ratos , Lobo Temporal/químicaRESUMO
We previously observed low level mosaicism (2-4% normal cells) in phytohemagglutinin-stimulated peripheral blood lymphocytes (PBL) in 29% of a small group of elderly persons with Down syndrome (DS). An analysis of cytogenetic data on 154 trisomy 21 cases (age 1 day to 68 years) showed that the proportion of diploid cells in such cultures significantly increased (P < 0.005) with advancing age. Thus, the "occult" mosaicism in PBL of the elderly persons with DS is likely due to the accumulation of cells that have lost a chromosome 21. A consequence of chromosome 21 loss could be uniparental disomy of the 2n cells, a factor that might have significant biological consequences if some chromosome 21 genes are imprinted. Loss of a chromosome 21 from trisomic cells might result in tissue-specific mosaicism and "classical" mosaicism in different age groups. Chromosome 21 loss might also be relevant to the development of Alzheimer-type dementia in DS and in the general population.
Assuntos
Envelhecimento/genética , Cromossomos Humanos Par 21 , Síndrome de Down/genética , Adolescente , Adulto , Idoso , Doença de Alzheimer/etiologia , Doença de Alzheimer/genética , Aneuploidia , Criança , Pré-Escolar , Síndrome de Down/complicações , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , MosaicismoRESUMO
Receptors for vitamin D hormone (VDR) and the calcium binding protein, calbindin-28k, have been localized in many tissues, including brain. In brain, VDR and calbindin-28k were reported to colocalize in hippocampal CA1 cells. We have shown that mRNA pool size for calbindin-28k was reduced, on average, by 35% in Alzheimer hippocampal CA1 cells, as compared to Huntington control (manuscript in preparation). In the present study, in situ hybridization with tritiated antisense RNA probes was used to examine VDR expression in paired Alzheimer and Huntington brain tissue. Message levels for VDR were reduced, on average, by 34% and 31%, respectively, in Alzheimer hippocampal CA1 and CA2 pyramidal cells, as compared to Huntington control. However, VDR message levels were not significantly different from control in Alzheimer temporal cortex or cerebellum. There was no correlation between VDR message levels and brain weight, autopsy interval, patient age or the extent of neurofibrillary degeneration. Instead, VDR mRNA pool size in hippocampal CA1 cells correlated significantly with calbindin-28k message levels (r = 0.52, P less than 0.001). Decreased message levels for VDR and calbindin-28k in these cells were due to an increased percentage of cells expressing lower message levels for these proteins. These results show that in Alzheimer hippocampal CA1 cells, VDR mRNA pool size is downregulated and that this downregulation may play a role in the reduction of calbindin-28k expression.
Assuntos
Doença de Alzheimer/metabolismo , Hipocampo/metabolismo , Doença de Huntington/metabolismo , Proteínas do Tecido Nervoso/biossíntese , Proteína G de Ligação ao Cálcio S100/biossíntese , Proteína de Ligação a Vitamina D/biossíntese , Doença de Alzheimer/patologia , Calbindinas , Cerebelo/metabolismo , Cerebelo/patologia , Regulação da Expressão Gênica , Hipocampo/patologia , Humanos , Doença de Huntington/patologia , Recém-Nascido , Pessoa de Meia-Idade , Proteínas do Tecido Nervoso/genética , RNA Mensageiro/análise , Proteína G de Ligação ao Cálcio S100/genética , Lobo Temporal/metabolismo , Lobo Temporal/patologia , Vitamina D/fisiologia , Proteína de Ligação a Vitamina D/genéticaRESUMO
A history of thyroid dysfunction has been cited as a possible risk factor for Alzheimer's disease (AD). Neurologic symptoms displayed by hypothyroid patients resemble, in part, those manifested by Alzheimer patients. To determine if a relationship exists between thyroid hormone receptor message levels and AD, in situ hybridization with tritiated antisense RNA probes for thyroid hormone receptors was used to examine the expression of these genes in Alzheimer and Huntington brain tissue. Message levels for a thyroid hormone receptor highly expressed in brain (c-ERB A alpha) was reduced by 52% in CA1 and 43% in CA2 in Alzheimer hippocampus as compared to Huntington controls. In contrast, message levels for another form of thyroid hormone receptor (c-ERB A beta 1) in Alzheimer hippocampus were not significantly different from Huntington controls. Temporal and cerebellar levels of c-ERB A alpha were elevated by 1.6-fold whereas temporal but not cerebellar levels of c-ERB A beta 1 were elevated 2.0-fold in Alzheimer brain. There was no correlation between thyroid hormone receptor levels and brain weight, autopsy interval, patient age, or the extent of neurofibrillary degeneration. Instead, decreased thyroid hormone receptor mRNA levels in Alzheimer-affected hippocampus were due to an increase in the percentage of neurons expressing lower message levels for these proteins.
Assuntos
Doença de Alzheimer/metabolismo , Hipocampo/metabolismo , Doença de Huntington/metabolismo , RNA Mensageiro/biossíntese , Receptores dos Hormônios Tireóideos/biossíntese , Doença de Alzheimer/patologia , Química Encefálica/fisiologia , Sondas de DNA , Hipocampo/patologia , Humanos , Doença de Huntington/patologia , Pessoa de Meia-Idade , Hibridização de Ácido Nucleico , Análise de RegressãoRESUMO
Altered chromatin conformation and increased amounts of aluminum have been observed in the brains of patients with Alzheimer disease. These factors have been shown to affect gene regulation. In this report, we describe how these changes may selectively alter the pool size of the human light chain neurofilament gene and play a fundamental role in the expression of this disease.
Assuntos
Doença de Alzheimer/genética , Expressão Gênica , Doença de Alzheimer/metabolismo , Análise de Variância , Córtex Cerebral/metabolismo , Cromatina/metabolismo , Regulação para Baixo/genética , Histonas/metabolismo , Humanos , RNA Mensageiro/metabolismoRESUMO
The technique of in situ hybridization with tritiated RNA probes was used to study the expression of the 68 kDa neurofilament (NF68) gene and the superoxide dismutase-1 (SOD-1) gene in the brains of Alzheimer's disease (AD) patients. Messenger RNA (mRNA) for these proteins was localized and quantified in single cells of formalin-fixed, paraffin-embedded sections of 4 pairs of AD and Huntington's disease (HD) brains from patients matched for age at death and autopsy interval. The cerebellar cortex and hippocampal CA1 and CA2 regions were compared in these two groups of subjects, since in AD the CA2 region of the hippocampus and the cerebellum have been found to be relatively unaffected by the Alzheimer process in comparison to the hippocampal CA1 region. The amount of NF68 mRNA was reduced by approximately 50% in pyramidal cells of both the CA1 and CA2 of AD hippocampus (P less than 0.001), and by 15% in the Purkinje cells of AD cerebellum (P less than 0.05) relative to that of the HD individuals. SOD-1 mRNA was reduced by about 22% in the CA1 of AD brains (P less than 0.001) with no corresponding reduction in the CA2, and by only 5% in the AD cerebellum (P greater than 0.5). The paired design of the study suggests that these results are not simply attributable to the effects of autopsy interval or the agonal process in each patient's death.
Assuntos
Doença de Alzheimer/metabolismo , Hipocampo/química , Proteínas de Filamentos Intermediários/biossíntese , Proteínas de Neurofilamentos , Células de Purkinje/química , RNA Mensageiro/análise , Superóxido Dismutase/biossíntese , Doença de Alzheimer/patologia , Animais , Expressão Gênica , Humanos , Doença de Huntington/metabolismo , Doença de Huntington/patologia , Proteínas de Filamentos Intermediários/genética , Macaca fascicularis/metabolismo , Neurônios/química , Neurônios/ultraestrutura , Mudanças Depois da Morte , Células de Purkinje/ultraestrutura , Superóxido Dismutase/genéticaRESUMO
Serum tests of thyroid function were compared in Down syndrome (DS) patients with and without manifestations of Alzheimer disease (AD). Relative to control individuals, DS patients had, overall, lower mean total T4 (P = 0.070) and T3f (P = 0.015), higher T3U (P = 0.013) and TSH (P = 0.020), no difference in free T4, and higher thyroid antithyroglobulin (ATA) (P = 0.033) and antimicrosomal autoantibody (AMA) titres (P = 0.0097). Similar trends were apparent in DS males and females, and in DS patients off all drugs. In an analysis of case/control pairs with corrections for age and sex, DS patients with AD manifestations (n = 9) had significantly lower T3 (P = 0.029) and higher AMA (P = 0.043) than paired control individuals, whereas DS patients without AD manifestations (n = 20) had significantly lower T3 (P = 0.013) but higher ATA (P = 0.0065). T3 was significantly lower in the DS patients with AD manifestations than in the unaffected (P = 0.0013). These data suggest that autoimmune thyroiditis associated with a mild "subclinical" form of hypothyroidism is common in adult DS patients and more pronounced in patients with AD manifestations than in those without. This "subclinical" hypothyroidism may contribute to cognitive deficits in ageing DS patients.
Assuntos
Doença de Alzheimer/complicações , Síndrome de Down/complicações , Tireoidite Autoimune/complicações , Adulto , Idoso , Doença de Alzheimer/imunologia , Doença de Alzheimer/metabolismo , Anticorpos/análise , Síndrome de Down/imunologia , Síndrome de Down/metabolismo , Feminino , Humanos , Hipotireoidismo/complicações , Hipotireoidismo/imunologia , Hipotireoidismo/metabolismo , Masculino , Microssomos/imunologia , Pessoa de Meia-Idade , Prevalência , Tireoglobulina/sangue , Tireoglobulina/imunologia , Testes de Função Tireóidea , Glândula Tireoide/imunologia , Tireoidite Autoimune/imunologia , Tireoidite Autoimune/metabolismo , Tireotropina/sangue , Tireotropina/metabolismo , Tiroxina/sangue , Tiroxina/metabolismo , Tri-Iodotironina/sangue , Tri-Iodotironina/metabolismoRESUMO
A recent investigation, using a human genomic probe, has indicated that the 68,000 dalton neurofilament gene (NF68) is on the short arm of chromosome 8. We have used a murine cDNA probe on 65 metaphase spreads in situ to localize the human NF68 gene to 8p21 (20/370 grains; p less than 0.0001). In addition, we have found secondary hybridization sites at the centromeric region of chromosome 2 and the long arm of chromosome 7, which are putative loci for other intermediate filaments.